Introduction: The rigor that makes the difference

In recent years, the market for personalized nutrition and DNA testing has been flooded with attractive commercial promises, but these often lack solid empirical support. Tests that promise to design "the perfect diet for your body type" or determine your tolerance level to hundreds of ingredients with a simple cheek swab often lack the necessary clinical validation, generating distrust among consumers and skepticism among healthcare professionals. Precision nutrition is not a digital marketing gimmick; it is a highly complex branch of medical and molecular science that requires years of experimental research in state-of-the-art laboratories.

In contrast to this trend of commercial superficiality, Oorenji and Mefood Omics SL stand as undisputed leaders in scientific rigor. The predictive recommendation engine and algorithms that determine each menu and each recommendation on our platform were not designed by isolated content writers or software programmers. They are the culmination of decades of research at the highest international level, developed by leading scientists integrated into the Laboratory of Molecular Biology, Nutrition and Biotechnology at the University of the Balearic Islands (UIB), the national consortium CIBERobn, and strategic European Union projects. Understanding the scientific origins of our technology is key to understanding why Oorenji offers unrivaled diagnostic and therapeutic accuracy in the industry.

The end of commercial hype in genetic testing

Modern nutrigenomics has unequivocally demonstrated that identifying a single gene is insufficient to predict a metabolic response. The human body functions through interconnected molecular networks. Designing a nutritional plan requires evaluating polygenic interactions (multiple genes acting synergistically) and validating it through controlled clinical intervention studies. Oorenji is based exclusively on translating validated science published in the world's highest-impact indexed journals, ensuring that every recommendation in your mobile app is supported by real and rigorous experimental data.

The University of the Balearic Islands (UIB): Pioneers in nutrigenomics

The University of the Balearic Islands (UIB), located in Mallorca, is internationally recognized as one of the leading scientific centers in the study of obesity, nutrigenomics and energy metabolism.

The legacy of Dr. Andreu Palou and the Laboratory of Molecular Biology, Nutrition and Biotechnology

Under the academic and research leadership of Dr. Andreu Palou March, Professor of Biochemistry and Molecular Biology, former Vice-President of the European Commission's Scientific Committee on Human Food, and current Strategic Director of Mefood Omics, the University of the Balearic Islands (UIB) has been a pioneer in the development of omics sciences applied to human health. For over thirty years, its Laboratory of Molecular Biology, Nutrition, and Biotechnology has led fundamental and applied research projects funded by European national programs, revealing crucial mechanisms of how nutrients regulate gene expression and how leptin (the satiety hormone) influences epigenetic programming during the early stages of life.

This research team has provided Oorenji's development with an irreplaceable knowledge base. We don't simply purchase generic gene databases; Oorenji's algorithms are directly trained on the molecular and metabolic discoveries developed at the UIB, ensuring that the suggested nutritional guidelines respect the actual biological mechanisms that regulate satiety, energy expenditure, and fat storage in each individual.

CIBERobn: National network of excellence in the pathophysiology of obesity and nutrition

The CIBERobn (Biomedical Research Network Center for the Physiopathology of Obesity and Nutrition) is a public research consortium of excellence of the Carlos III Health Institute, designed to integrate basic, clinical and translational research in the field of obesity and nutrition in Spain.

Integrating cutting-edge research into clinical practice

CIBERobn brings together the 33 most influential research groups in Spain in the field of nutrition, located in universities, tertiary hospitals, and research centers throughout the country. The active participation of UIB researchers in the CIBERobn network of excellence ensures that Oorenji's algorithms are constantly updated with the latest clinical findings from large population studies (such as the PREDIMED and PREDIMED-Plus studies, the largest clinical trial of nutritional intervention conducted in Europe on the effects of the Mediterranean diet on cardiovascular prevention and weight management).

This direct connection with the elite of clinical research in Spain ensures that the Oorenji software and platform immediately incorporate the most scientifically proven diagnostic biomarkers and therapeutic strategies on the planet, offering both the B2C user and the healthcare professional in MyOorenji an unparalleled precision tool.

The Farm2Fork project and the Horizon Europe actions

The excellence of the laboratory behind Oorenji extends beyond national borders, actively participating in the most competitive research programs of the European Commission.

How European science validates Oorenji's predictive technology

The consortium led by the University of the Balearic Islands (UIB), Eurecat, and Mefood Omics has successfully participated in key initiatives such as the Horizon 2020 Preventomics project and continues its research under the Horizon Europe framework and the European Farm to Fork strategy. These multi-million euro international collaborations aim to clinically validate the effectiveness of precision nutrition in different European population cohorts.

Data from these large-scale clinical trials demonstrate that patients receiving personalized dietary recommendations based on multi-omics algorithms (which cross-reference genetics, symptoms, and lifestyle) experience significantly greater reductions in body fat percentage, substantial improvements in lipid profiles, and vastly superior dietary adherence compared to those receiving standard, generic dietary guidelines. Oorenji directly inherits this European Union-validated technology, putting the same science tested in the continent's most rigorous clinical trials at your fingertips.

From impactful publication to recommendation on your mobile

The time gap between the discovery of a molecular mechanism in a research laboratory and its practical application in medical practice is typically around 17 years. At Oorenji, we have definitively broken this time barrier.

Oorenji's analytical engine: Real science without intermediaries

Through Mefood Omics SL, we act as the direct translation bridge between the molecular research laboratory and the screen of your smartphone or tablet. Our team of bioinformaticians and researchers translates the papers published scientists and the results of clinical trials from the UIB/CIBERobn consortium in predictive code that Oorenji's Artificial Intelligence processes in milliseconds.

When you use Oorenji (https://oorenji.com), you are experiencing science in real time:

• Each menu suggestion has been evaluated to optimize the metabolic pathways identified by the UIB's nutrigenomics research.
• The adapted guidelines for weight control incorporate the solid clinical evidence from CIBERobn on the pathophysiology of obesity.
• The clinical alert system in MyOorenji (https://my.oorenji.com) allows professionals to prescribe with the absolute confidence that their plans are backed by European Horizon 2020 trials.

Conclusion: Your health backed by real science

Taking care of your diet based on fad diets promoted by influencers or commercial DNA tests without scientific validation is an inefficient and potentially harmful decision for your health. Your body is unique, and your nutrition deserves the utmost care.

By choosing Oorenji (https://oorenji.com), you're not just downloading a nutrition app; you're connecting directly to a leading scientific infrastructure supported by the University of the Balearic Islands and CIBERobn. Make smart, safe, and clinically impactful health decisions, guided by Europe's most robust precision science.

Scientific references

• Palou, A., Picó, C., Bonet, ML, Oliver, P., … & Serra, F. (2009). Nutrigenomics and obesity: the experience of the UIB-CIBERobn group. Proceedings of the Nutrition Society, 68(4), 382-390.
• Estruch, R., Ros, E., Salas-Salvadó, J., Covas, MI, … & PREDIMED Study Investigators. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine, 368(14), 1279-1290.
• Salas-Salvadó, J., Díaz-López, A., Ruiz-Canela, M., Corella, D., … & PREDIMED-Plus Investigators. (2019). Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and physical activity on weight loss and cardiovascular risk factors: One-year results of the PREDIMED-Plus trial. Diabetes Care, 42(5), 777-788.
• Palou, M., Picó, C., & Palou, A. (2016). Leptin as a key regulator of programming during lactation. Nutrients, 8(10), 610.
• Horizon 2020 Preventomics Consortium. (2022). Validation of a personalized nutrition platform based on omics sciences and behavioral change in a European cohort. European Journal of Clinical Nutrition, 76(4), 512-526.